<SEC-DOCUMENT>0001193125-22-301911-index.html : 20221212
<SEC-HEADER>0001193125-22-301911.hdr.sgml : 20221212
<ACCEPTANCE-DATETIME>20221209174309
ACCESSION NUMBER:		0001193125-22-301911
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20221209
FILED AS OF DATE:		20221212
DATE AS OF CHANGE:		20221209

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Autolus Therapeutics plc
		CENTRAL INDEX KEY:			0001730463
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38547
		FILM NUMBER:		221455777

	BUSINESS ADDRESS:	
		STREET 1:		THE MEDIAWORKS
		STREET 2:		191 WOOD LANE
		CITY:			LONDON
		STATE:			X0
		ZIP:			W12 7FP
		BUSINESS PHONE:		44 20 3829 6230

	MAIL ADDRESS:	
		STREET 1:		THE MEDIAWORKS
		STREET 2:		191 WOOD LANE
		CITY:			LONDON
		STATE:			X0
		ZIP:			W12 7FP

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Autolus Therapeutics Ltd
		DATE OF NAME CHANGE:	20180205
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d368050d6k.htm
<DESCRIPTION>6-K
<TEXT>
Document 1 - file: d368050d6k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d368050dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
Document 2 - file: d368050dex11.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>d368050dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 3 - file: d368050dex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>d368050dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 4 - file: d368050dex991.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g368050g1209205352834.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: g368050g1209205352834.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g368050g21c95.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: g368050g21c95.jpg

</DOCUMENT>
</SEC-DOCUMENT>